Application of epithelial membrane protein 2 targeted agents in the treatment of lung diseases

CN112118867BActive Publication Date: 2025-01-10美国卫生与公众服务部长代表部门
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN201980029352.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2018-11-26
Filing Date
2019-04-30
Publication Date
2025-01-10
Estimated Expiration
2039-04-30

Smart Images

  • Figure CN112118867B_ABST
    Figure CN112118867B_ABST
Patent Text Reader

Abstract

Disclosed herein are methods for treating or preventing lung disease, comprising administering to a subject a composition comprising an agent that modulates the activity and / or expression of epithelial membrane protein 2 (EMP2) in an effective amount, treating or preventing lung disease, and compositions for use in the method.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Electronic jacquard needle selector

    CN1200156C

  • Field pipe well water pumping apparatus

    CN2521259Y

  • Three component chimeric antisense oligonucleotides

    US5849902A

  • EMP2 regulates angiogenesis in cancer cells through induction of VEGF

    US20150079089A1